Mark Hartman Email & Phone Number

The Chief Commercial Officer (CCO) brings to Exela Pharma Sciences (Exela) exceptional commercial knowledge experience as well as an excellent track record of growth within a pharmaceutical company, specialty and/or branded generics. The CCO will serve as the key leader in refining and executing the company’s commercialization strategy and process, as well.

GRAYKEY, LLC is a Consulting firm specializing in the pharmaceutical environment and related fields. I founded the company to bring my 27+ years of Brand, Generic and OTC pharmaceutical sales, marketing and management experience to organizations looking to understand this very dynamic and complex marketplace. Through my years of experience in the.

Waltham, Massachusetts, US

As Sr. VP/GM, I will have full P&L responsibility for Patheon's newly acquired business, Banner Life Sciences (formerly Banner Pharmacaps), which will include the RX, OTC and Nutritional product lines utilizing Banner's proprietary soft gel technology platforms. Delivered high EBITDA performance on introduction of three generic Rx soft gel products.

Bridgeton, MO, US

President of KV's generic subsidiary, Nesher Pharmaceuticals. Relaunched Generic subsidiary in November 2010. Gained 40% Market Share on key product with annual revenue approximately $40mn. Led the Strategic Initiative to sell the generic subsidiary to a strategic partner or financial party.Completed $60mn sale transaction in August 2011 to Zydus.

Mumbai, IN

President North America, Wockhardt, USA responsible for all aspects of Wockhardts efforts in North America including Morton Grove pharmaceuticals. Established process improvements that quickly improved service levels and supply chain effectiveness in a global network. Stabilized Wockhardt USA as a reputable, go to generic company. Improved cost efficiency.

Working as an independent consultant for pharmaceutical firms desiring knowledge on the establishment of generic or specialty pharma companies in the US. Particular expertise in managing global businesses who desire to have a footprint in North America. Open to new start up ventures or assisting existing player to go to the next step in their evolution.

Hyderabad, TS, IN

Launched Dr. Reddy’s direct generic presence in North America via establishment of complete front end commercial order to cash operations, including Sales, Marketing, Supply Chain, Customer Service, Warehouse & Distribution. Led strategic direction for business development, legal and product selection. Member of Dr. Reddy’s Management Council. Responsible.

Dublin, IE

• Built Sales & Marketing teams of Watson's Generic division. Full P&L responsibility, including involvement in product selection, BD strategy and M&A activities. Officer of the company and on the Executive Committee..
• Integrated 4 company acquisitions: Oclassen (dermatology specialty company), Royce Laboratories, Rugby Laboratories, and Schein Pharmaceuticals (generic companies). Developed combined company strategies and trade.

US

Directed overall marketing efforts of $120 M liquid and topical generic prescription drug line. Established marketing, pricing and contracting policies for prescription drug line. Responsible for the name change and integration of Barre-National into Alpharma in 1996.

Began pharmaceutical career carrying a bag and detailing physicians. Won Rookie of the Year as Field rep. Promoted to Hospital rep, then Clinical Conference Manager, then District Sales Manager, then Product Manager in Marketing on Brand side before moving over the Lederle Standard Products (generics) marketing prior to sale of American Cyanamid.